Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access programGiuseppe Procopio, Giacomo Cartenì, Enrico Cortesi et al.|Journal for ImmunoTherapy of Cancer|2019Cited by 140